“Neurotransmitters in the TME: Can Dopamine and Glutamate Be the Next Cancer Targets?”, J Biomol Pathog Ther, vol. 2, no. 3, pp. 111–112, Sep. 2026, doi: 10.68041/jbpt.v2i3/01.